CSS LLC’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

CSS LLC’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-68,700	Closed	-$183K	–	1055
2024 Q1	$183K	Buy	+68,700	New	+$170K	0.01%	659

CSS LLC's KNTE Position: Q2 2024 in Review

CSS LLC sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 584 shares — an estimated $1.55K sold.

CSS LLC first reported a position in KNTE in Q1 2024 and held it in 1 quarter. The position peaked at $1.55K in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

CSS LLC reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
CSS LLC sold 584 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $1.55K.
CSS LLC first reported a position in Kinnate Biopharma Inc. Common Stock in Q1 2024 and held it in 1 quarter.
CSS LLC's Kinnate Biopharma Inc. Common Stock position peaked at $1.55K in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on CSS LLC's 13F filing for Q2 2024, filed 14 Aug 2024.